Track the CJ 바이오사이언스 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, CJ 바이오사이언스 has recorded 22 public disclosures. Market capitalisation: €691.7m. The latest transaction was reported on 19 December 2024 (Purchase). Among the most active insiders: CJ제일제당. Every trade is accessible without an account.
22
Insider Decl.
n/a
Thresholds
n/a
22 ops.
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,220 of 28,124 companies
45.1
score / 100
Value
47
Quality
43
FCF yld-27%
Earn yld4.5%
EV/EBITDA8.0x
ROE-0.0%
Gross mgn75%
Net mgn2.6%
Debt/EBITDA5.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.